BlackRock Health Sciences Opportunities Portfolio

Scorecard
4 / 5 Stars
Lipper
---
Zacks Investment Research
3 (Hold)
Standard & Poor's
2 / 5 Stars
TheStreet.com
---

Fund Holdings

Asset Allocation

% Long % Short % Net
Cash 2.2 0.42 1.78
Stocks 81.51 0.0 81.51
Bonds 0.0 0.0 0.0
Other 0.38 0.04 0.34
Foreign Bonds 0.0 0.0 0.0
Foreign Stocks 16.37 0.0 16.37
Convertible 0.0 0.0 0.0
Preferred 0.0 0.0 0.0

Updated 01.31.2014

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 01.31.2014

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 8.46 4.19
Biogen Idec Inc BIIB 21.04 3.85
Johnson & Johnson JNJ 0.69 3.64
Celgene Corporation CELG -5.14 3.41
Pfizer Inc PFE 5.26 3.22
AbbVie Inc ABBV -4.39 2.92
Bayer AG BAYN --- 2.68
Alexion Pharmaceuticals, Inc. ALXN 29.76 2.59
Roche Holding AG RHHVF 4.05 2.38
Merck & Co Inc MRK 12.73 2.35